Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.06.2012 | Case report

Sulprostone

Hyperthermia and neurological disorders: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Cellier Q, Gamerre L, Cortey C, Clement H-J, Viale J-P.Severe hyperthermia and neurological disorders following prostaglandin treatment for uterine atonia after caesarean section. Annales Francaises d'Anesthesie et de Reanimation 31: 243-245, No. 3, Mar 2012. Available from: URL: http://dx.doi.org/10.1016/j.annfar.2012.01.001 - France Cellier Q, Gamerre L, Cortey C, Clement H-J, Viale J-P.Severe hyperthermia and neurological disorders following prostaglandin treatment for uterine atonia after caesarean section. Annales Francaises d'Anesthesie et de Reanimation 31: 243-245, No. 3, Mar 2012. Available from: URL: http://​dx.​doi.​org/​10.​1016/​j.​annfar.​2012.​01.​001 - France
Metadaten
Titel
Sulprostone
Hyperthermia and neurological disorders: case report
Publikationsdatum
01.06.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214060-00120

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Rifampicin